MabSwitch Inc, is a biotechnology company founded to develop and commercialize novel innovative products based on it’s proprietary Universal Allosteric linker and Switch Module for Antibodies (UNASMA™) technology that facilitates the regulation of virtually any antibody’s affinity for it’s target under physiological conditions